Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.72 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.72 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.72 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.67 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.54 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.54 |
| ▸ | APP | P05067 | 1/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.52 |
| ▸ | LMNA | P02545 | 2/20 | 0.52 |
| ▸ | RECQL | P46063 | 2/20 | 0.52 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | GAA | P10253 | 2/20 | 0.50 |
| ▸ | JAK2 | O60674 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.48 |
| ▸ | CRHBP | P24387 | 1/20 | 0.46 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29708563 | 1.00 | CYP1A2 (0.72) | CYP1A2CYP2C9CYP2C19ALDH1A1ADRA2B | |
| Potassium SCHEMBL30586884 | 0.97 | CYP1A2 (0.69) | CYP1A2CYP2C9CYP2C19ALDH1A1ADRA2B | |
| SCHEMBL17537502 | 0.93 | CYP1A2 (0.64) | CYP1A2CYP2C9CYP2C19ALDH1A1ADRA2B | |
| SCHEMBL13435256 | 0.93 | CYP1A2 (0.64) | CYP1A2CYP2C9CYP2C19ALDH1A1ADRA2B | |
| SCHEMBL13531826 | 0.93 | CYP1A2 (0.64) | CYP1A2CYP2C9CYP2C19ALDH1A1ADRA2B | |
| SCHEMBL10387995 | 0.92 | CYP1A2 (0.76) | CYP1A2CYP2C9CYP2C19ALDH1A1ADRA2B | |
| SCHEMBL10386552 | 0.92 | CYP1A2 (0.76) | CYP1A2CYP2C9CYP2C19ALDH1A1ADRA2B | |
| SCHEMBL23493019 | 0.90 | CYP1A2 (0.73) | CYP1A2CYP2C9CYP2C19ALDH1A1ADRA2B | |
| SCHEMBL3358175 | 0.90 | CYP1A2 (0.73) | CYP1A2CYP2C9CYP2C19ALDH1A1ADRA2B | |
| SCHEMBL23493031 | 0.90 | CYP1A2 (0.73) | CYP1A2CYP2C9CYP2C19ALDH1A1ADRA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 402 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260062538-A1 | Composition Comprising an Alkyd Resin | Munditia Technologies GmbH (DE) | 2026-03-05 | — | — | US | claimed |
| EP-3705582-B1 | COMPOSITIONS AND METHODS FOR DNA AND RNA EXTRACTION FROM TISSUE SAMPLES | CEPHEID (US) | 2025-09-03 | — | — | EP | claimed |
| EP-4222493-B1 | SCREENING TEST FOR CATSPER MODULATORS | UNIV MUENSTER WESTFAELISCHE WILHELMS (DE) | 2025-04-30 | — | — | EP | claimed |
| EP-3965885-B1 | METHODS AND COMPOSITIONS FOR REVERSING PLATELET CLUMPING | TRUVIAN SCIENCES INC (US) | 2025-03-26 | — | — | EP | claimed |
| WO-2025049920-A1 | METHODS AND COMPOSITIONS FOR SAMPLE PROCESSING | Biomeme, Inc. (US) | 2025-03-06 | — | — | WO | claimed |
| CN-119463795-A | Adhesive, negative electrode plate and battery | 深圳好电科技有限公司 | 2025-02-18 | — | — | CN | claimed |
| WO-2025032220-A1 | LIQUID BOTULINUM TOXIN FORMULATION AND USE THEREOF | MERZ PHARMA GMBH & CO. KGAA (DE) | 2025-02-13 | — | — | WO | claimed |
| CN-118755440-B | Insulating adhesive, positive plate and secondary battery | 深圳好电科技有限公司 | 2025-02-11 | — | — | CN | claimed |
| US-20240360434-A1 | METHOD FOR ISOLATING NUCLEIC ACIDS FROM A FORMALDEHYDE RELEASER STABILIZED SAMPLE | QIAGEN GMBH (DE) | 2024-10-31 | — | — | US | claimed |
| CN-118755440-A | Insulating adhesive, positive plate and secondary battery | 深圳好电科技有限公司 | 2024-10-11 | — | — | CN | claimed |
| EP-1295913-A2 | Pigment, method for producing pigment, pigment dispersion, and electrostatic image developing powder toner | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2003-03-26 | — | — | EP | claimed |
| US-20030040559-A1 | Organic pigment with high transparency and hydrophobicity | CLARIANT FINANCE (BVI) LIMITED (VG) | 2003-02-27 | — | — | US | claimed |
| US-20020055619-A1 | Process for preparing azo colorants | CLARIANT GMBH | 2002-05-09 | — | — | US | claimed |
| EP-1195411-A1 | Process for the preparation of azo colourants | Clariant GmbH (DE) | 2002-04-10 | — | — | EP | claimed |
| EP-0705886-B1 | Pigments for electrophotographic toners and developers | CLARIANT GMBH (DE) | 2001-06-20 | — | — | EP | claimed |
| EP-0691852-A1 | PRODRUGS WITH ENHANCED PENETRATION INTO CELLS | D-PHARM, LTD. (IL) | 1996-01-17 | — | — | EP | claimed |
| EP-0542790-A4 | — | PROMEGA CORP (US) | 1995-02-08 | — | — | EP | claimed |
| WO-1994022483-A2 | PRODRUGS WITH ENHANCED PENETRATION INTO CELLS | D-PHARM, LTD. (IL) | 1994-10-13 | — | — | WO | claimed |
| EP-0542790-A1 | METHOD AND KIT FOR THE SEPARATION, CONCENTRATION AND ANALYSIS OF CELLS | PROMEGA CORPORATION (US) | 1993-05-26 | — | — | EP | claimed |
| WO-1992000317-A1 | METHOD AND KIT FOR THE SEPARATION, CONCENTRATION AND ANALYSIS OF CELLS | PROMEGA CORPORATION (US) | 1992-01-09 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260062538-A1 | Composition Comprising an Alkyd Resin | SORD, GCDH, OGDH | CYP1A2 2076/4885CYP2C9 2447/4885CYP2C19 3290/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.